웹2024년 7월 12일 · The additional funding will allow us to further strengthen and expand our integrated R&D capability, grow and broaden our innovative product pipeline, and prepare for multiple IND submissions in 2024 and beyond," said Baiteng Zhao, PhD, co-founder, CEO, and Chair of the Board of ProfoundBio. 웹2024년 3월 10일 · ProfoundBio首席执行官Baiteng Zhao(赵柏腾)博士表示:“首先,我很高兴Chen博士加入ProfoundBio领导团队。她顶尖的科学背景和药物开发专业知识将进一步加强我们在ADC发现和开发方面的能力,同时也将加快我们新型专利技术从实验到临床的转化。
Abstract 2469: Brentuximab vedotin-mediated immunogenic cell …
웹2024년 2월 10일 · At ProfoundBio, Baiteng Zhao has 5 colleagues including Qiang Tian (Senior Vice President), Zhu Chen (Science) …. Industry Colleagues. In the Biotechnology industry, Baiteng Zhao has 28,487 colleagues in 2,146 companies located in 41 countries. 14,440 executive movements have been recorded in the last 12 months. Learn more about … 웹View Baiteng Zhao's record in Bellevue, WA including current phone number, address, relatives, background check report, and property record with Whitepages. Menu Log In … cyberplanet full
Abstract - American Association for Cancer Research
웹2024년 6월 15일 · Baiteng Zhao 3 ProfoundBio US Co., ProfoundBio (Suzhou) Co., Woodinville, WA. Search for other works by this author on: This Site. PubMed. Google … 웹2024년 8월 3일 · Baiteng Zhao, CEO at ProfoundBio, said: “Earlier this year, the PRO1184 preclinical data presented at AACR annual meeting demonstrated potent anti-tumor activity in multiple mouse CDX models and a favorable therapeutic index. With the US FDA clearance for the PRO1184 first-in-human study, ... 웹Baiteng Zhao May Sutherland CD33 is expressed on the surface of myeloblasts in 85 to 90% of patients with AML and represents a promising target regardless of age, risk factors, or … cyberplan software